Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor
about
Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathwaysEffect of nonsteroidal anti-inflammatory drugs on beta-catenin protein levels and catenin-related transcription in human colorectal cancer cellsAntimetastatic activity of a cyclooxygenase-2 inhibitorCOX-2 and cancer: a new approach to an old problemRoles of arrest-defective protein 1(225) and hypoxia-inducible factor 1alpha in tumor growth and metastasisRole of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experienceEffect of nimesulide on proliferation and apoptosis of human hepatoma SMMC-7721 cells.Apoptosis of human gastric cancer SGC-7901 cells induced by mitomycin combined with sulindac.Mouse models of colorectal cancer.Non-Steroidal Anti-Inflammatory Drugs in the Carcinogenesis of the Gastrointestinal Tract.Mouse models expressing human carcinoembryonic antigen (CEA) as a transgene: evaluation of CEA-based cancer vaccines.Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposis.cPLA2 is protective against COX inhibitor-induced intestinal damage.Cyclooxygenases and lipoxygenases in cancer.Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP.The chromosomal instability pathway in colon cancerCannabinoids and cancer: pros and cons of an antitumour strategy.Prevention of carcinogenesis and cancer metastasis by bovine lactoferrin.Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system.Discovery of a 29-gene panel in peripheral blood mononuclear cells for the detection of colorectal cancer and adenomas using high throughput real-time PCR.Non-steroidal anti-inflammatory drugs and colorectal cancer preventionAntitumor activity of the MEK inhibitor trametinib on intestinal polyp formation in Apc(Δ716) mice involves stromal COX-2.Monocyte chemoattractant protein 1 and macrophage cyclooxygenase 2 expression in colonic adenoma.Cyclooxygenase-2 expression and its association with thyroid lesionsExpression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma.Nimesulide inhibits proliferation via induction of apoptosis and cell cycle arrest in human gastric adenocarcinoma cell line.Characterization of the MUC1.Tg/MIN transgenic mouse as a model for studying antigen-specific immunotherapy of adenomas.Clinicopathological Significance of VEGF-C, VEGFR-3 and Cyclooxygenase-2 in Early-Stage Cervical Cancer.Colorectal cancer carcinogenesis: a review of mechanismsInhibition of the mTORC1 pathway suppresses intestinal polyp formation and reduces mortality in ApcDelta716 mice.11β-Hydroxysteroid Dehydrogenase Type II is a Potential Target for Prevention of Colorectal TumorigenesisInhibitory effect of interferon-alpha-2b on expression of cyclooxygenase-2 and vascular endothelial growth factor in human hepatocellular carcinoma inoculated in nude mice.Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic miceThe Role of Inflammation in the Pathogenesis of Colorectal Cancer.6-C-(E-phenylethenyl)-naringenin suppresses colorectal cancer growth by inhibiting cyclooxygenase-1.Targeted Cox2 gene deletion in intestinal epithelial cells decreases tumorigenesis in female, but not male, ApcMin/+ miceThe targets of curcumin.COX-Independent Mechanisms of Cancer Chemoprevention by Anti-Inflammatory Drugs.Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc Min/+ mouse model of intestinal tumorigenesis.Cyclooxygenase 2 modulates killing of cytotoxic T lymphocytes by colon cancer cells.
P2860
Q26748123-618AB246-EC59-492C-9F3F-39CE71B9FDCCQ28168895-BD3536CA-0B13-4C10-AED4-C6F6B80851F8Q28169082-23320B73-ACB6-4A7E-8A9A-F9E0BE6B9AC9Q28191533-0EF32460-9256-4278-ABC6-C04F9CF13C8EQ28274705-2D9901F2-E3A2-4EC6-9551-BA53D18173EDQ28303196-1CA08820-F035-44CB-9F4E-3CE23DE92B40Q31066911-3520D1D9-E6D4-49DC-8128-33128CB7A132Q31156666-807F174D-DAA9-4A20-A79D-6E7B26F3932EQ33579734-CC3A7911-77BB-4BB4-9C96-F1E8635AA7E4Q33664095-1FE060F0-7172-497F-98E2-A5E3B3129E56Q33754989-DFA3119D-A4EE-4158-877F-DEA21271FED7Q34045455-E6276D98-647A-456E-B28B-F7836127C5D2Q34072006-4B355D7A-4AA5-4165-A684-4C325505F5EEQ34224752-97B0EADE-4126-4CDB-89A7-1F4328526E4CQ34306499-86D18632-9103-4C79-B1A8-FCB9C7A43994Q34570062-A2003901-EAD4-4980-ABBC-ED55FF6F30C4Q35100892-8B3E7B0B-B6B9-4B80-8983-35737C88671AQ35128660-0806A177-4B2A-4478-ADB8-C6DEC38874B3Q35128757-E9FAFF65-8E0F-442C-AEDD-65E549778904Q35391746-2C5BD053-F875-4377-8857-94A9F0EAA963Q35521719-80231834-225A-4B16-84FE-0FC3DB71BA23Q35754265-A3C4E683-A5DD-4946-B59A-739958E14488Q35760820-ACC4E64D-1986-45B1-A729-3F8C939C73D1Q35817689-7654F44A-F06B-4ED2-AD6B-26CB654018C4Q36178297-546B9A82-F047-42B5-B229-83D4F33C47DEQ36178536-0287D1FD-7719-410E-BC46-B7F11D0EC417Q36625526-4D92E437-2540-4657-8BD9-B8D0D6C3878CQ36735345-2D8ABAA9-65FB-4B99-A7F0-9424D8247FADQ36849645-664BABE7-6150-4FEB-837D-5AC23CAA170DQ36869970-F04D4E69-EBC2-494D-AD67-CE7C4288C616Q37078077-633C7100-DFC4-49FE-9AA7-35D408B79ED4Q37413261-DC7243D6-4A13-4477-96F5-55D5CBEEC9F2Q37544417-9039215C-FB04-4E19-BD0C-F8C080503FEDQ37597899-FBC7212B-1CAF-4C14-906E-D7179850A1BCQ37626259-36AC0F1E-709E-41EE-B6DC-4BE19BC3D29DQ37658563-AB2342ED-3838-41E4-9F30-F7C3B61F8C8FQ37800949-202DB653-4979-444A-A8DE-F1F8A87DEACEQ38123175-B991EAA2-C045-48CF-8E31-669B56A5243FQ41075575-86409560-7482-4F9C-B8D0-E34A4533BFDBQ42093459-61397384-BD7C-4062-AC18-0ABE857D8EF8
P2860
Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor
description
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im Februar 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2001/02/15)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd op 2001/02/15)
@nl
наукова стаття, опублікована в лютому 2001
@uk
مقالة علمية (نشرت في 15-2-2001)
@ar
name
Chemoprevention of intestinal ...... fic cyclooxygenase-2 inhibitor
@ast
Chemoprevention of intestinal ...... fic cyclooxygenase-2 inhibitor
@en
Chemoprevention of intestinal ...... fic cyclooxygenase-2 inhibitor
@nl
type
label
Chemoprevention of intestinal ...... fic cyclooxygenase-2 inhibitor
@ast
Chemoprevention of intestinal ...... fic cyclooxygenase-2 inhibitor
@en
Chemoprevention of intestinal ...... fic cyclooxygenase-2 inhibitor
@nl
prefLabel
Chemoprevention of intestinal ...... fic cyclooxygenase-2 inhibitor
@ast
Chemoprevention of intestinal ...... fic cyclooxygenase-2 inhibitor
@en
Chemoprevention of intestinal ...... fic cyclooxygenase-2 inhibitor
@nl
P2093
P1433
P1476
Chemoprevention of intestinal ...... fic cyclooxygenase-2 inhibitor
@en
P2093
J. F. Evans
M. Arguello
M. M. Taketo
S. Kargman
P304
P407
P577
2001-02-15T00:00:00Z